BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/14/2025 7:42:32 AM | Browse: 7 | Download: 15
 |
Received |
|
2025-03-05 11:12 |
|
Peer-Review Started |
|
2025-03-05 11:12 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2025-03-21 07:29 |
|
Revised |
|
2025-04-04 03:33 |
|
Second Decision |
|
2025-04-21 02:35 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2025-04-21 06:47 |
|
Articles in Press |
|
2025-04-21 06:47 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2025-05-06 10:50 |
|
Typeset the Manuscript |
|
2025-10-08 09:16 |
|
Publish the Manuscript Online |
|
2025-10-14 07:42 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Letter to the Editor |
| Article Title |
MEX3A: A promising prognostic marker and therapeutic target in hepatocellular carcinoma
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Xin-Le Yang and Xiao-Jun Yang |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Xiao-Jun Yang, Professor, Department of General Surgery, Gansu Provincial People’s Hospital, No. 199 Donggang West Road, Chengguan District, Lanzhou 730000, Gansu Province, China. yangxjmd@aliyun.com |
| Key Words |
MEX3A; Hepatocellular carcinoma; Immune microenvironment; Cancer stem cells; Immunotherapy; Organoids |
| Core Tip |
Ji et al’s study explored MEX3A’s role in hepatocellular carcinoma, showing its potential as a marker and target. It has limitations such as small sample size. New directions include studying its relations with immune microenvironment and cancer stem cells, such as analyzing the composition of immune cells and detecting the effect of knockdown of MEX3A on immunotherapy. Addressing them may improve hepatocellular carcinoma prognosis. |
| Publish Date |
2025-10-14 07:42 |
| Citation |
<p>Yang XL, Yang XJ. MEX3A: A promising prognostic marker and therapeutic target in hepatocellular carcinoma. <i>World J Gastrointest Oncol</i> 2025; 17(10): 106692</p> |
| URL |
https://www.wjgnet.com/1948-5204/full/v17/i10/106692.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v17.i10.106692 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
